STAT3 and cancer: Importantly, pharmacological inhibition of STAT3 has demonstrated the ability to suppress OSCC growth and diminish cancer stem cell characteristics, underscoring its potential as a therapeutic target to improve treatment outcomes and overcome resistance mechanisms in OSCC [46].